Evidence map›Paper›PMID 40206334›Full record

ArticleIDCases2024

Insight into ocular complications of West Nile Virus: A case report of chorioretinal scarring.

Hamza Inayat, Anna Branch, James J Armstrong, Verena Juncal, Courtney Casserly

Abstract readCase Reports
In one paragraph

Article in IDCases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hamza InayatSchulich School of Medicine & Dentistry, Western University, London, Ontario, Canada.
Anna BranchDepartment of Clinical Neurological Sciences, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada.
James J ArmstrongDepartment of Ophthalmology, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada.
Verena JuncalDepartment of Ophthalmology, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada.
Courtney CasserlyDepartment of Clinical Neurological Sciences, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This case report aims to emphasize the significance of the ocular manifestations in individuals with West Nile Virus (WNV) infection, with primary neurological involvement. By presenting a case of chorioretinal scarring secondary to WNV, we highlight the importance of a thorough ophthalmological evaluation in suspected cases of WNV to identify potential sight-threatening complications. Observations: A 63-year-old woman presented with neurological symptoms following a trip to Denver, USA, including headaches, fever, and decreased consciousness. Despite initial treatment for suspected meningoencephalitis, her condition deteriorated, leading to focal seizures and profound weakness. Ophthalmological examination revealed chorioretinal lesions consistent with WNV retinopathy. Conclusions: and Importance: WNV can present with neurological symptoms, and ocular complications can lead to significant visual impairment. This case report highlights the importance of asking individuals with suspected WNV about ocular symptoms. Despite the absence of a preventive treatment for ocular manifestations, clinicians must stay attentive to ocular symptoms in patients to mitigate potential complications, such as chorioretinal neovascularization, which can be treated with anti-vascular endothelial growth factor therapy injections.

Indexed as

Chorioretinal ScarRetinaWest Nile Virus

Identifiers

PMID40206334
PMCPMC11980620

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.